Who owns Voyager Therapeutics, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from SEC filings.
Institutional ownership of VYGR from SEC Form 13F filings across 101 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 101 institutions disclosed 23.0M shares of Voyager Therapeutics, Inc. worth $78.5M — about 38% of shares outstanding; the largest disclosed holder is BlackRock, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.
101
13F holders
$78.5M
value, 2026 filers
38%
of shares outstanding (23.0M sh)
14
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30· % of fund = share of the manager's own book · % of co. = share of VYGR's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 5.2M | $18.1M | 0.0% | 8.5% | -7.1% |
| 2 | MILLENNIUM MANAGEMENT LLC | 4.4M | $15.6M | 0.0% | 7.3% | +29.6% |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 2.3M | $8.2M | 0.0% | 3.9% | -48.6% |
| 4 | GEODE CAPITAL MANAGEMENT, LLC | 1.3M | $4.7M | 0.0% | 2.2% | +26.7% |
| 5 | TWO SIGMA INVESTMENTS, LP | 948,517 | $3.3M | 0.0% | 1.6% | +54.1% |
| 6 | VANGUARD PORTFOLIO MANAGEMENT LLC | 810,091 | $2.8M | 0.0% | 1.3% | +11.6% |
| 7 | CITADEL ADVISORS LLC | 784,067 | $2.7M | 0.0% | 1.3% | +115.0% |
| 8 | MORGAN STANLEY | 697,334 | $2.4M | 0.0% | 1.2% | +2.3% |
| 9 | ACADIAN ASSET MANAGEMENT LLC | 428,670 | $1,496 | 0.0% | 0.7% | +72.2% |
| 10 | DIADEMA PARTNERS LP | 413,642 | $1.4M | 0.2% | 0.7% | -2.4% |
| 11 | NORTHERN TRUST CORP | 411,803 | $1.4M | 0.0% | 0.7% | +7.0% |
| 12 | GOLDMAN SACHS GROUP INC | 338,477 | $1.2M | 0.0% | 0.6% | -20.8% |
| 13 | VANGUARD FIDUCIARY TRUST CO | 337,325 | $1.2M | 0.0% | 0.6% | +13.1% |
| 14 | Fiduciary Trust Co | 334,397 | $1.2M | 0.0% | 0.6% | 0.0% |
| 15 | JPMORGAN CHASE & CO | 276,211 | $988,836 | 0.0% | 0.5% | -0.2% |
| 16 | Point72 Asset Management, L.P. | 236,083 | $826,291 | 0.0% | 0.4% | -12.0% |
| 17 | Invesco Ltd. | 212,349 | $743,222 | 0.0% | 0.4% | +78.2% |
| 18 | Qube Research & Technologies Ltd | 194,049 | $679,172 | 0.0% | 0.3% | +1008.5% |
| 19 | FMR LLC | 175,868 | $615,537 | 0.0% | 0.3% | +7.4% |
| 20 | PRICE T ROWE ASSOCIATES INC /MD/ | 155,526 | $545 | 0.0% | 0.3% | +32.8% |
| 21 | Sixth Street Partners Management Company, L.P.NEW | 151,451 | $530,079 | 0.1% | 0.3% | new |
| 22 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 151,451 | $530,079 | 0.0% | 0.3% | +21.1% |
| 23 | AMERICAN CENTURY COMPANIES INC | 146,874 | $514,059 | 0.0% | 0.2% | -0.5% |
| 24 | Bank of New York Mellon Corp | 146,556 | $512,946 | 0.0% | 0.2% | +4.9% |
| 25 | D. E. Shaw & Co., Inc. | 143,992 | $503,973 | 0.0% | 0.2% | +45.9% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.